Our goal is
early breast cancer detection.
Breathe BioMedical® is developing breath analytics technology that could be a simple but valuable addition to tools used for breast cancer detection in women with dense breast tissue.
Breathe BioMedical is developing a powerful platform technology designed to detect diseases in exhaled breath. Our primary focus is to create a breath test that could make the early detection of breast cancer in women with dense breast tissue, as easy as breathing.
Of the women eligible for breast cancer screening, approximately 50% of women have dense breast tissue, which makes them 4 to 5 times more likely to develop breast cancer than women without dense breast tissue. Although mammography is the current gold standard for breast cancer screening, the interpretation of a mammogram can be especially challenging with dense breast tissue, because both tumors and dense breast tissue appear white on a mammogram.
Evidence suggests that mammography alone fails to detect breast cancer in 30-50% of women with dense breast tissue. This clearly highlights the unmet clinical need for a test that is sensitive enough to detect breast cancer in all women, including those with dense breast tissue.
Our technology is designed to identify biomarkers of disease. We have active studies underway and believe this technology could support early-breast cancer detection, and in the future, revolutionize early-disease detection.
The SohnoXB® breath sampler allows for individuals to provide a breath sample, which could then be analyzed for combinations of biomarkers indicative of disease.
Just breathe®
Our Vision
A new paradigm for early-disease detection that improves quality of life and saves lives.
Our Mission
Revolutionizing early-disease detection with our breath-based platform technology.
Our Focus
To develop an accurate breath test to detect early-stage breast cancer in women.
Our Safety Statement: Always asking, “Is this safe?” – Our safety mindset.
Our Core Values
Breathe BioMedical has established core values that guide our work internally and externally.
We live by these values daily.
COMMUNICATION
Honest and timely sharing of information fostering a culture of connectedness.
INTEGRITY
Implementing and complying with industry best practices fostering a culture of quality and respect.
INNOVATION
Creating solutions to difficult problems fostering a culture of technical excellence.
COLLABORATION
Effective engagement fostering a culture of productivity.
ACCOUNTABILITY
Holding ourselves collectively and personally responsible for our work fostering a culture of trust.
ISO 13485 Certified
Breathe BioMedical’s quality management system (QMS) is ISO 13485 certified. ISO 13485 is an international standard for quality systems for medical device manufacturers across the globe. This certification demonstrates, by third party review, that Breathe BioMedical’s full end-to-end quality management system meets the highest standard for safety and quality.
ISO Certification